Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
It is no secret that screening mammography has a beneficial impact on reducing deaths related to breast cancer. But, what does that effect really look like – how significant can it be? This week, look for coverage of how participating in routine screening mammography actually impacts mortality rates.
For more screening mammography coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Later this week, the European Congress of Radiology (ECR) will host its 2021 virtual annual meeting. Diagnostic Imaging will bring you the latest news across all the modalities, as well as the details you need for greater workflow productivity and improved facility management. Watch for coverage to begin mid-week.
To review last year’s coverage, click here.
Recent research revealed that transgender patients have had mixed results – at best – with their radiology encounters. Nearly 75 percent of these patients have reported at least one negative experience with an imaging provider. This week, Diagnostic Imaging will publish coverage of a study published in the Journal of the American College of Radiology about best practices for radiologists to provide the highest level of care possible for transgender patients.
For additional coverage on imaging transgender patients, click here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.